| Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy MC Johnston, CJ Scott Drug Discovery Today: Technologies 30, 63-69, 2018 | 79 | 2018 |
| Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours WJ McDaid, MK Greene, MC Johnston, E Pollheimer, P Smyth, ... Nanoscale 11 (42), 20261-20273, 2019 | 46 | 2019 |
| Star polymers with acid-labile diacetal-based cores synthesized by aqueous RAFT polymerization for intracellular DNA delivery TJ Gibson, P Smyth, M Semsarilar, AP McCann, WJ McDaid, ... Polymer Chemistry 11 (2), 344-357, 2020 | 30 | 2020 |
| Nanomedicine in pancreatic cancer: current status and future opportunities for overcoming therapy resistance MK Greene, MC Johnston, CJ Scott Cancers 13 (24), 6175, 2021 | 24 | 2021 |
| DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models MC Johnston, JA Nicoll, KM Redmond, P Smyth, MK Greene, WJ McDaid, ... Journal of controlled release 324, 610-619, 2020 | 24 | 2020 |
| Development of an advanced nanoformulation for the intracellular delivery of a caspase-3 selective activity-based probe F Cogo, M Poreba, W Rut, K Groborz, P Smyth, MC Johnston, R Williams, ... Nanoscale 11 (2), 742-751, 2019 | 7 | 2019 |
| Lysosomal cysteine proteases are mediators of cell death in macrophages following exposure to amorphous silica nanoparticles F Ishaq, N Sereesongsaeng, MC Johnston, CJ Scott, RE Burden Chemico-biological interactions 356, 109882, 2022 | 4 | 2022 |
| Efficacy of DR5-targeted immunoliposomes in pancreatic cancer models primed with SMO inhibitors D Chan, C Minx, J Wang, A Sen, M Johnston, WW Ma, CJ Scott, ... Cancer Research 78 (13_Supplement), 3704-3704, 2018 | | 2018 |
